Professional Documents
Culture Documents
Aspergillus
Aspergillus
CLINICAL RECORD
© JLO (1984) Limited, 2010
doi:10.1017/S0022215110001623
Abstract
Objectives: We report a case of otogenic fungal pachymeningitis in a diabetic patient who presented with multiple
cranial nerve palsies and nasopharyngeal swelling.
Methods: We present a case report, we describe the investigations, management and clinical course of fungal
pachymeningitis, and we present a review of the world literature on fungal and non-fungal pachymeningitis.
Results: To our knowledge, this is the first report of fungal pachymeningitis with magnetic resonance imaging
features suggestive of nasopharyngeal carcinoma. It is also the first reported case with aspergillus cultured from
both a dural biopsy and the ear canal.
Conclusion: Fungal pachymeningitis is a rare condition which may present to otorhinolaryngologists. Its clinical
and radiological findings can be confused with those of nasopharyngeal carcinoma; fungal pachymeningitis should
thus be included in the differential diagnosis of nasopharyngeal carcinoma.
Accepted for publication 16 April 2010 First published online 27 September 2010
104 H S CHAN, H Y YUEN, W K NG et al.
FIG. 2
Positron emission tomography scan showing increased fluoro-deoxy-glucose uptake deep to the left posterolateral nasopharyngeal wall
(maximum standardised uptake value = 3.7). A = anterior; P = posterior; R = right; L = left
spread from the ear, nasal sinuses or lungs to the CNS. Gadolinium-enhanced MRI is an indispensable tool
The presence of aspergillus in both an ear swab and an which facilitates the diagnosis of pachymenigitis and
ipsilateral dural biopsy would suggest an otogenic localises the affected meninges for subsequent dural
source of the CNS infection. Cases of non-fungal biopsy.1 More subtle foci of pachymeningitis can be
pachymeningitis secondary to ear infections are well localised using PET, as in our patient. Dural biopsy is
documented in the literature; most are inflammatory the ‘gold standard’ for establishing the diagnosis of
in nature.6,7 Headache is the commonest symptom, fungal pachymeningitis.
and most such headaches are chronic and severe.1,3 The treatment of fungal pachymeningitis is not well
The thickening of the meninges encasing the cranial established due to the lack of reported cases. The stan-
nerves results in their inflammation and ischaemia, dard steroid regime used for idiopathic cranial pachy-
and ultimately in nerve paralysis.2 meningitis may not be applicable when an infective
Detection of fungal infection in the CNS is difficult. agent is present. In our patient, antifungal treatment
However, immunoassay for fungal cell wall components was given empirically to treat fungal meningitis.
now provides a sensitive tool for the detection of fungal Surgical decompression of involved cranial nerves
infections in CSF specimens. Relevant fungal wall com- has been reported in idiopathic cases, with mixed
ponents include β-D-glucan, a non-specific polysaccharide results.1–3 The clinical course of fungal pachymeningi-
present in most fungal cell walls, and galactomannan, tis is unpredictable and can be fatal despite antifungal
which is more specific to aspergillus species.8,9 treatment.4,5
106 H S CHAN, H Y YUEN, W K NG et al.
References
1 Kupersmith MJ, Martin V, Heller G, Shah A, Mitnick HJ.
Idiopathic hypertrophic pachymeningitis. Neurology 2004;62:
FIG. 4 686–94
Axial, T1-weighted magnetic resonance image of the nasopharynx 2 Hatano N, Behari S, Nagatani T, Kimura M, Ooka K, Saito K
showing a large submucosal nasopharyngeal carcinoma (arrow) et al. Idiopathic hypertrophic cranial pachymeningitis: clinicor-
deep to the right fossa of Rosenmüller. The overlying mucosa adiological spectrum and therapeutic options. Neurosurgery
appeared intact on endoscopy. 1999;45:1336–42
CLINICAL RECORD 107
3 Rossi S, Giannini F, Cerase A, Bartalini S, Tripodi S, Volpi N 10 Vlantis AC, Tsang RK, Yu BK, Kam MK, Tong MC, Lo PS
et al. Uncommon findings in idiopathic hypertrophic cranial et al. Nasopharyngectomy and surgical margin status: a survival
pachymeningitis. J Neurol 2004;251:548–55 analysis. Arch Otolaryngol Head Neck Surg 2007;133:
4 Murai H, Kira J, Kobayashi T, Goto I, Inoue H, Hasuo K. 1296–301
Hypertrophic cranial pachymeningitis due to Aspergillus 11 Pak MW, Chan KL, van Hasselt CA. Retropharyngeal abscess.
flavus. Clin Neurol Neurosurg 1992;94:247–50 A rare presentation of nasopharyngeal carcinoma. J Laryngol
5 Ismail AR, Clifford L, Meacock WR. Compressive optic neuro- Otol 1999;113:70–2
pathy in fungal hypertrophic cranial pachymeningitis. Eye 2007;
21:568–9
6 Iwasaki S, Ito K, Sugasawa M. Hypertrophic cranial pachyme- Address for correspondence:
ningitis associated with middle ear inflammation. Otol Dr H S Chan,
Neurotol 2006;27:928–33 Department of Otorhinolaryngology Head and Neck Surgery,
7 Kanzaki S, Inoue Y, Watabe T, Ogawa K. Hypertrophic chronic Prince of Wales Hospital,
pachymeningitis associated with chronic otitis media and mas- Shatin, NT, Hong Kong SAR, China
toiditis. Auris Nasus Larynx 2004;31:155–9
8 Wasser SP, Weis AL. Therapeutic effects of substance occurring Fax: 852 2632 4679
in higher Basidiomycetes mushrooms: a modern perspective. E-mail: dearhs@gmail.com
Crit Rev Immunol 1999;19:65–96
9 Bart-Delabesse E, Basile M, Al Jijakli A, Souville D, Gay F,
Dr H S Chan takes responsibility for the integrity of the
Philippe B et al. Detection of aspergillus galactomannan antige-
content of the paper
nemia to determine biological and clinical implications of beta-
Competing interests: None declared
lactam treatments. J Clin Microbiol 2005;43:5214–20
Copyright of Journal of Laryngology & Otology is the property of Cambridge University Press and its content
may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express
written permission. However, users may print, download, or email articles for individual use.